Publicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (9)

2023

  1. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

    Epilepsy and Behavior, Vol. 145

2022

  1. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Epilepsy and Behavior, Vol. 137

2019

  1. Use of intravenous brivaracetam in status epilepticus: A multicenter registry

    Epilepsia, Vol. 60, Núm. 8, pp. 1593-1601

2018

  1. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study

    Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752

  2. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures

    Acta Neurologica Scandinavica, Vol. 138, Núm. 2, pp. 122-129

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131

2014

  1. Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study

    Epilepsy Research, Vol. 108, Núm. 7, pp. 1243-1252

2012

  1. Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study

    Movement Disorders, Vol. 27, Núm. 2, pp. 211-218